Tag: generic drug submission
Learn the most common FDA deficiency letter findings in generic drug applications and how to avoid them. Get data-backed insights on dissolution, impurities, manufacturing, and bioequivalence issues that delay approval.
Learn the most common FDA deficiency letter findings in generic drug applications and how to avoid them. Get data-backed insights on dissolution, impurities, manufacturing, and bioequivalence issues that delay approval.